2xpe Citations

Structural characterisation of Tpx from Yersinia pseudotuberculosis reveals insights into the binding of salicylidene acylhydrazide compounds.

Abstract

Thiol peroxidase, Tpx, has been shown to be a target protein of the salicylidene acylhydrazide class of antivirulence compounds. In this study we present the crystal structures of Tpx from Y. pseudotuberculosis (ypTpx) in the oxidised and reduced states, together with the structure of the C61S mutant. The structures solved are consistent with previously solved atypical 2-Cys thiol peroxidases, including that for "forced" reduced states using the C61S mutant. In addition, by investigating the solution structure of ypTpx using small angle X-ray scattering (SAXS), we have confirmed that reduced state ypTpx in solution is a homodimer. The solution structure also reveals flexibility around the dimer interface. Notably, the conformational changes observed between the redox states at the catalytic triad and at the dimer interface have implications for substrate and inhibitor binding. The structural data were used to model the binding of two salicylidene acylhydrazide compounds to the oxidised structure of ypTpx. Overall, the study provides insights into the binding of the salicylidene acylhydrazides to ypTpx, aiding our long-term strategy to understand the mode of action of this class of compounds.

Reviews - 2xpe mentioned but not cited (1)

  1. Peroxiredoxins wear many hats: Factors that fashion their peroxide sensing personalities. Bolduc J, Koruza K, Luo T, Malo Pueyo J, Vo TN, Ezeriņa D, Messens J. Redox Biol 42 101959 (2021)


Reviews citing this publication (5)

  1. Chemical inhibitors of the type three secretion system: disarming bacterial pathogens. Duncan MC, Linington RG, Auerbuch V. Antimicrob Agents Chemother 56 5433-5441 (2012)
  2. Targeting the type III secretion system to treat bacterial infections. Marshall NC, Finlay BB. Expert Opin Ther Targets 18 137-152 (2014)
  3. Development of antivirulence compounds: a biochemical review. Zambelloni R, Marquez R, Roe AJ. Chem Biol Drug Des 85 43-55 (2015)
  4. Weak protein-ligand interactions studied by small-angle X-ray scattering. Tuukkanen AT, Svergun DI. FEBS J 281 1974-1987 (2014)
  5. From screen to target: insights and approaches for the development of anti-virulence compounds. Beckham KS, Roe AJ. Front Cell Infect Microbiol 4 139 (2014)

Articles citing this publication (5)

  1. Small-molecule inhibitors suppress the expression of both type III secretion and amylovoran biosynthesis genes in Erwinia amylovora. Yang F, Korban SS, Pusey PL, Elofsson M, Sundin GW, Zhao Y. Mol Plant Pathol 15 44-57 (2014)
  2. The bacterial type III secretion system as a target for developing new antibiotics. McShan AC, De Guzman RN. Chem Biol Drug Des 85 30-42 (2015)
  3. Salicylidene Acylhydrazides and Hydroxyquinolines Act as Inhibitors of Type Three Secretion Systems in Pseudomonas aeruginosa by Distinct Mechanisms. Anantharajah A, Buyck JM, Sundin C, Tulkens PM, Mingeot-Leclercq MP, Van Bambeke F. Antimicrob Agents Chemother 61 e02566-16 (2017)
  4. A small-molecule compound belonging to a class of 2,4-disubstituted 1,3,4-thiadiazine-5-ones suppresses Salmonella infection in vivo. Nesterenko LN, Zigangirova NA, Zayakin ES, Luyksaar SI, Kobets NV, Balunets DV, Shabalina LA, Bolshakova TN, Dobrynina OY, Gintsburg AL. J Antibiot (Tokyo) 69 422-427 (2016)
  5. Crystal and solution structural studies of mouse phospholipid hydroperoxide glutathione peroxidase 4. Janowski R, Scanu S, Niessing D, Madl T. Acta Crystallogr F Struct Biol Commun 72 743-749 (2016)


Related citations provided by authors (1)

  1. Identification of bacterial target proteins for the salicylidene acylhydrazide class of virulence-blocking compounds.. Wang D, Zetterström CE, Gabrielsen M, Beckham KS, Tree JJ, Macdonald SE, Byron O, Mitchell TJ, Gally DL, Herzyk P, Mahajan A, Uvell H, Burchmore R, Smith BO, Elofsson M, Roe AJ J Biol Chem 286 29922-31 (2011)